| Spirig HealthCare AG - Lansoprazol Spirig HC 15 mg, magensaftresistente Hartkapseln | | 70352 | | 01 | | Lansoprazol Spirig HC 15 mg | | magensaftresistente Hartkapseln | | A02BC03 | | Lansoprazol | | 01.07.2025 | | |
| | Composition | | lansoprazolum 15 mg, sacchari sphaerae cum saccharum max. 108.734 mg et maydis amylum, natrii laurilsulfas, megluminum, mannitolum, hypromellosum, macrogolum 6000, talcum, polysorbatum 80, E 171, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, Kapselhülle: gelatina, E 104, E 171, pro capsula corresp. natrium 0.00056 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Lansoprazole | 15 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lansoprazole | 15 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici | | | | E 104 | | color. | | E 171 | | color. | | Ethylis Acrylatis Polymerisatum Dispersio | 30 | | | Gelatina | | Kapselhülle | | Hypromellosum | | | | Macrogol | 6000 | | | Mannitol | | | | Maydis Amylum | | | | Meglumine | | | | Natrii Laurilsulfas | | | | Per Centum | | | | Polysorbatum 80 | | | | Sacchari Sphaerae cum Saccharum | 108.734 mg | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 14 | 4.98 | 14.65 | B | LS | Non | | 002 | 28 | 9.92 | 27.20 | B | LS | Non | | 003 | 56 | 15.43 | 33.30 | B | LS | Non | | 004 | 112 | | | B | | Non | | 005 | 2 x 56 | 28.47 | 47.45 | B | LS | Non |
|
|
